Geode Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-470,631
| Closed | -$45.6M | – | 4263 |
|
2019
Q3 | $45.6M | Buy |
470,631
+24,262
| +5% | +$2.35M | 0.01% | 939 |
|
2019
Q2 | $45.7M | Buy |
446,369
+48,960
| +12% | +$5.01M | 0.01% | 921 |
|
2019
Q1 | $45.3M | Buy |
397,409
+27,409
| +7% | +$3.12M | 0.01% | 891 |
|
2018
Q4 | $14.5M | Buy |
370,000
+33,414
| +10% | +$1.31M | ﹤0.01% | 1507 |
|
2018
Q3 | $18.4M | Buy |
336,586
+12,444
| +4% | +$679K | 0.01% | 1473 |
|
2018
Q2 | $26.8M | Buy |
324,142
+30,076
| +10% | +$2.49M | 0.01% | 1142 |
|
2018
Q1 | $19.6M | Buy |
294,066
+17,747
| +6% | +$1.18M | 0.01% | 1280 |
|
2017
Q4 | $14.2M | Buy |
276,319
+4,304
| +2% | +$221K | ﹤0.01% | 1500 |
|
2017
Q3 | $24.3M | Buy |
272,015
+72,974
| +37% | +$6.51M | 0.01% | 1097 |
|
2017
Q2 | $11.9M | Buy |
199,041
+21,887
| +12% | +$1.31M | ﹤0.01% | 1544 |
|
2017
Q1 | $9.45M | Buy |
177,154
+8,284
| +5% | +$442K | ﹤0.01% | 1654 |
|
2016
Q4 | $8.43M | Buy |
168,870
+5,883
| +4% | +$294K | ﹤0.01% | 1699 |
|
2016
Q3 | $9.79M | Buy |
162,987
+12,413
| +8% | +$745K | ﹤0.01% | 1512 |
|
2016
Q2 | $7.7M | Buy |
150,574
+50,009
| +50% | +$2.56M | ﹤0.01% | 1628 |
|
2016
Q1 | $2.97K | Buy |
100,565
+8,289
| +9% | +$245 | ﹤0.01% | 2193 |
|
2015
Q4 | $4.18M | Buy |
92,276
+13,868
| +18% | +$628K | ﹤0.01% | 1991 |
|
2015
Q3 | $3.27M | Buy |
78,408
+20,023
| +34% | +$835K | ﹤0.01% | 2121 |
|
2015
Q2 | $3.52M | Buy |
+58,385
| New | +$3.52M | ﹤0.01% | 2141 |
|